Cargando…

Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis

PURPOSE: With the gradual increase in the incidence of upper-tract urothelial carcinoma (UTUC), its metastatic disease has attracted much attention. The prognosis of UTUC patients with bone metastasis is worse than that of UTUC patients with other metastases. Therefore, the current study is performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Mingping, Zhang, Jianxin, Chen, Xiaowei, Wang, Zhan, Liang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468251/
https://www.ncbi.nlm.nih.gov/pubmed/36111229
http://dx.doi.org/10.3389/fsurg.2022.928294
_version_ 1784788369764515840
author Zhou, Mingping
Zhang, Jianxin
Chen, Xiaowei
Wang, Zhan
Liang, Wei
author_facet Zhou, Mingping
Zhang, Jianxin
Chen, Xiaowei
Wang, Zhan
Liang, Wei
author_sort Zhou, Mingping
collection PubMed
description PURPOSE: With the gradual increase in the incidence of upper-tract urothelial carcinoma (UTUC), its metastatic disease has attracted much attention. The prognosis of UTUC patients with bone metastasis is worse than that of UTUC patients with other metastases. Therefore, the current study is performed to analyze the clinicopathologic features and survival predictors among UTUC patients with bone metastasis. PATIENTS AND METHODS: We reviewed the Surveillance, Epidemiology, and End Results (SEER) database to select cases diagnosed with UTUC and bone metastasis at present from 2010 to 2016. Overall survival (OS) and cancer-specific survival (CSS) were first performed by applying univariate Cox regression analysis. Then we performed multivariate Cox analysis to determine independent predictors of survival. Forest plots were drawn by GraphPad 8.0.1 and used to visually display the results of multivariate analysis. Kaplan-Meier method was applied to intuitively show the prognosis difference of each independent risk factor. RESULTS: We finally identified 380 UTUC patients with bone metastasis for survival analysis, of which 230 males (60.5%) and 150 females (39.5%). The mean and median age at diagnosis were 71 and 72 years, respectively. Simultaneous lung metastasis (33.4%) and liver metastasis (31.1%) were more common in UTUC patients with bone metastasis. The 1-year OS and CSS rates of this research population were 23.8% and 26.6%, respectively. Multivariate Cox proportional hazards modeling controlling for surgery, chemotherapy, brain metastasis, liver metastasis, lung metastasis, and marital status, revealed that surgery, chemotherapy, no liver metastasis, no lung metastasis, and married status predicted for better OS and CSS. CONCLUSION: Surgery and chemotherapy are optimal management of UTUC patients with bone metastasis. Active treatments on lung and liver metastases should be performed. The prognosis of patients with unmarried status or others should be further improved.
format Online
Article
Text
id pubmed-9468251
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94682512022-09-14 Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis Zhou, Mingping Zhang, Jianxin Chen, Xiaowei Wang, Zhan Liang, Wei Front Surg Surgery PURPOSE: With the gradual increase in the incidence of upper-tract urothelial carcinoma (UTUC), its metastatic disease has attracted much attention. The prognosis of UTUC patients with bone metastasis is worse than that of UTUC patients with other metastases. Therefore, the current study is performed to analyze the clinicopathologic features and survival predictors among UTUC patients with bone metastasis. PATIENTS AND METHODS: We reviewed the Surveillance, Epidemiology, and End Results (SEER) database to select cases diagnosed with UTUC and bone metastasis at present from 2010 to 2016. Overall survival (OS) and cancer-specific survival (CSS) were first performed by applying univariate Cox regression analysis. Then we performed multivariate Cox analysis to determine independent predictors of survival. Forest plots were drawn by GraphPad 8.0.1 and used to visually display the results of multivariate analysis. Kaplan-Meier method was applied to intuitively show the prognosis difference of each independent risk factor. RESULTS: We finally identified 380 UTUC patients with bone metastasis for survival analysis, of which 230 males (60.5%) and 150 females (39.5%). The mean and median age at diagnosis were 71 and 72 years, respectively. Simultaneous lung metastasis (33.4%) and liver metastasis (31.1%) were more common in UTUC patients with bone metastasis. The 1-year OS and CSS rates of this research population were 23.8% and 26.6%, respectively. Multivariate Cox proportional hazards modeling controlling for surgery, chemotherapy, brain metastasis, liver metastasis, lung metastasis, and marital status, revealed that surgery, chemotherapy, no liver metastasis, no lung metastasis, and married status predicted for better OS and CSS. CONCLUSION: Surgery and chemotherapy are optimal management of UTUC patients with bone metastasis. Active treatments on lung and liver metastases should be performed. The prognosis of patients with unmarried status or others should be further improved. Frontiers Media S.A. 2022-08-30 /pmc/articles/PMC9468251/ /pubmed/36111229 http://dx.doi.org/10.3389/fsurg.2022.928294 Text en © 2022 Zhou, Zhang, Chen, Wang and Liang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Zhou, Mingping
Zhang, Jianxin
Chen, Xiaowei
Wang, Zhan
Liang, Wei
Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis
title Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis
title_full Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis
title_fullStr Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis
title_full_unstemmed Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis
title_short Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis
title_sort clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468251/
https://www.ncbi.nlm.nih.gov/pubmed/36111229
http://dx.doi.org/10.3389/fsurg.2022.928294
work_keys_str_mv AT zhoumingping clinicalfeaturesandprognosticindicatorsinuppertracturothelialcarcinomawithbonemetastasis
AT zhangjianxin clinicalfeaturesandprognosticindicatorsinuppertracturothelialcarcinomawithbonemetastasis
AT chenxiaowei clinicalfeaturesandprognosticindicatorsinuppertracturothelialcarcinomawithbonemetastasis
AT wangzhan clinicalfeaturesandprognosticindicatorsinuppertracturothelialcarcinomawithbonemetastasis
AT liangwei clinicalfeaturesandprognosticindicatorsinuppertracturothelialcarcinomawithbonemetastasis